C4 Therapeutics stock price target raised to $10 by Wells Fargo on positive data
PositiveFinancial Markets

C4 Therapeutics has received a boost as Wells Fargo raised its stock price target to $10, following promising data from recent studies. This positive outlook reflects confidence in the company's potential and could attract more investors, highlighting the importance of ongoing research and development in the biotech sector.
— Curated by the World Pulse Now AI Editorial System